首页 | 本学科首页   官方微博 | 高级检索  
     

心肌缺血再灌注损伤相关细胞因子及细胞通路研究进展
引用本文:高夏青综述,薛凌 审校. 心肌缺血再灌注损伤相关细胞因子及细胞通路研究进展[J]. 中国动脉硬化杂志, 2013, 21(6): 562-566
作者姓名:高夏青综述  薛凌 审校
作者单位:辽宁医学院附属第三医院,辽宁省锦州市,121000
基金项目:辽宁省科技厅项目(项目编号:2011225015)
摘    要:心肌缺血再灌注损伤是心肌梗死急性治疗所不可避免的一种损害,它是由多种炎症因子及多细胞信号通路参与的复杂的炎症损伤反应,其具体机制涉及氧化应激、线粒体损伤及钙超载等,目前很多研究旨在探索其发生机制,以便尽可能减小这种损伤.新的因子和靶作用位点不断被发现,对未来临床治疗提供了新的方向.

关 键 词:缺血再灌注损伤  细胞因子  细胞通路
收稿时间:2012-12-21

Advances in Myocardial Ischemia Reperfusion Injury and Its Related Cytokines and Cellular Pathways
GAO Xia-Qing,and XUE Ling. Advances in Myocardial Ischemia Reperfusion Injury and Its Related Cytokines and Cellular Pathways[J]. Chinese Journal of Arteriosclerosis, 2013, 21(6): 562-566
Authors:GAO Xia-Qing  and XUE Ling
Affiliation:The Third Affiliated Hospital of Liaoning Medical College,Jinzhou,Liaoning 121000,China
Abstract:Ischemia reperfusion injury is inevitable in the treatment for acute myocardial infarction. It is a complicated inflammatory response involved by variety of inflammatory cytokines and cellular pathways,which involved in oxidative stress,mitochondrial damage and calcium overload. To make the injury minimize,many researhes were carried on to explore the specific mechanisms. The discovery of new cytokines and target sites provide us new orientation for clinical treatment.
Keywords:Ischemia Reperfusion Injury  Cytokines  Cellular Pathway
本文献已被 万方数据 等数据库收录!
点击此处可从《中国动脉硬化杂志》浏览原始摘要信息
点击此处可从《中国动脉硬化杂志》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号